Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice

Takuji Torimura, Takato Ueno, Eitaro Taniguchi, Hiroshi Masuda, Hideki Iwamoto, Toru Nakamura, Kinya Inoue, Osamu Hashimoto, Mitsuhiko Abe, Hironori Koga, Vincenza Barresi, Emi Nakashima, Hirohisa Yano, Michio Sata

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The drug delivery system to tumors is a critical factor in upregulating the effect of anticancer drugs and reducing adverse events. Recent studies indicated selective migration of bone marrowderived endothelial progenitor cells (EPC) into tumor tissues. Cytosine deaminase (CD) transforms nontoxic 5-fluorocytosine (5-FC) into the highly toxic 5-fluorouracil (5-FU). We investigated the antitumor effect of a new CD/5-FC system with CD cDNA transfected EPC for hepatocellular carcinoma (HCC) in mice. We used human hepatoma cell lines (HuH-7, HLF, HAK1-B, KYN-2, KIM-1) and a rat EPC cell line (TR-BME-2). Escherichia coli CD cDNA was transfected into TR-BME-2 (CD-TR-BME). The inhibitory effect of 5-FU on the proliferation of hepatoma cell lines and the inhibitory effect of 5-FU secreted by CD-TR-BME and 5-FC on the proliferation of cocultured hepatoma cells were evaluated by a tetrazolium-based assay. In mouse subcutaneous xenograft models of KYN-2 and HuH-7, CD-TR-BME was transplanted intravenously followed by 5-FC injection intraperitoneally. HuH-7 cells were the most sensitive to 5-FU and KYN-2 cells were the most resistant. CD-TR-BME secreted 5-FU and inhibited HuH-7 proliferation in a 5-FC dosedependent manner. CD-TR-BME were recruited into the tumor tissues and some were incorporated into tumor vessels. Tumor growth of HuH-7 was significantly suppressed during 5-FC administration. No bodyweight loss, ALT abnormality or bone marrow suppression was observed. These findings suggest that our new CD/5-FC system with CD cDNA transfected EPC could be an effective and safe treatment for suppression of 5-FU-sensitive HCC growth.

Original languageEnglish
Pages (from-to)542-548
Number of pages7
JournalCancer Science
Volume103
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Cytosine Deaminase
Flucytosine
Liver Neoplasms
Fluorouracil
Growth
Neoplasms
Hepatocellular Carcinoma
Complementary DNA
Cell Line
Endothelial Progenitor Cells
Poisons
Drug Delivery Systems
Drug-Related Side Effects and Adverse Reactions
Heterografts

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice. / Torimura, Takuji; Ueno, Takato; Taniguchi, Eitaro; Masuda, Hiroshi; Iwamoto, Hideki; Nakamura, Toru; Inoue, Kinya; Hashimoto, Osamu; Abe, Mitsuhiko; Koga, Hironori; Barresi, Vincenza; Nakashima, Emi; Yano, Hirohisa; Sata, Michio.

In: Cancer Science, Vol. 103, No. 3, 2012, p. 542-548.

Research output: Contribution to journalArticle

Torimura, T, Ueno, T, Taniguchi, E, Masuda, H, Iwamoto, H, Nakamura, T, Inoue, K, Hashimoto, O, Abe, M, Koga, H, Barresi, V, Nakashima, E, Yano, H & Sata, M 2012, 'Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice', Cancer Science, vol. 103, no. 3, pp. 542-548. https://doi.org/10.1111/j.1349-7006.2011.02182.x
Torimura, Takuji ; Ueno, Takato ; Taniguchi, Eitaro ; Masuda, Hiroshi ; Iwamoto, Hideki ; Nakamura, Toru ; Inoue, Kinya ; Hashimoto, Osamu ; Abe, Mitsuhiko ; Koga, Hironori ; Barresi, Vincenza ; Nakashima, Emi ; Yano, Hirohisa ; Sata, Michio. / Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice. In: Cancer Science. 2012 ; Vol. 103, No. 3. pp. 542-548.
@article{c12fdbfa3e74415f834d0562540f6bf3,
title = "Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice",
abstract = "The drug delivery system to tumors is a critical factor in upregulating the effect of anticancer drugs and reducing adverse events. Recent studies indicated selective migration of bone marrowderived endothelial progenitor cells (EPC) into tumor tissues. Cytosine deaminase (CD) transforms nontoxic 5-fluorocytosine (5-FC) into the highly toxic 5-fluorouracil (5-FU). We investigated the antitumor effect of a new CD/5-FC system with CD cDNA transfected EPC for hepatocellular carcinoma (HCC) in mice. We used human hepatoma cell lines (HuH-7, HLF, HAK1-B, KYN-2, KIM-1) and a rat EPC cell line (TR-BME-2). Escherichia coli CD cDNA was transfected into TR-BME-2 (CD-TR-BME). The inhibitory effect of 5-FU on the proliferation of hepatoma cell lines and the inhibitory effect of 5-FU secreted by CD-TR-BME and 5-FC on the proliferation of cocultured hepatoma cells were evaluated by a tetrazolium-based assay. In mouse subcutaneous xenograft models of KYN-2 and HuH-7, CD-TR-BME was transplanted intravenously followed by 5-FC injection intraperitoneally. HuH-7 cells were the most sensitive to 5-FU and KYN-2 cells were the most resistant. CD-TR-BME secreted 5-FU and inhibited HuH-7 proliferation in a 5-FC dosedependent manner. CD-TR-BME were recruited into the tumor tissues and some were incorporated into tumor vessels. Tumor growth of HuH-7 was significantly suppressed during 5-FC administration. No bodyweight loss, ALT abnormality or bone marrow suppression was observed. These findings suggest that our new CD/5-FC system with CD cDNA transfected EPC could be an effective and safe treatment for suppression of 5-FU-sensitive HCC growth.",
author = "Takuji Torimura and Takato Ueno and Eitaro Taniguchi and Hiroshi Masuda and Hideki Iwamoto and Toru Nakamura and Kinya Inoue and Osamu Hashimoto and Mitsuhiko Abe and Hironori Koga and Vincenza Barresi and Emi Nakashima and Hirohisa Yano and Michio Sata",
year = "2012",
doi = "10.1111/j.1349-7006.2011.02182.x",
language = "English",
volume = "103",
pages = "542--548",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice

AU - Torimura, Takuji

AU - Ueno, Takato

AU - Taniguchi, Eitaro

AU - Masuda, Hiroshi

AU - Iwamoto, Hideki

AU - Nakamura, Toru

AU - Inoue, Kinya

AU - Hashimoto, Osamu

AU - Abe, Mitsuhiko

AU - Koga, Hironori

AU - Barresi, Vincenza

AU - Nakashima, Emi

AU - Yano, Hirohisa

AU - Sata, Michio

PY - 2012

Y1 - 2012

N2 - The drug delivery system to tumors is a critical factor in upregulating the effect of anticancer drugs and reducing adverse events. Recent studies indicated selective migration of bone marrowderived endothelial progenitor cells (EPC) into tumor tissues. Cytosine deaminase (CD) transforms nontoxic 5-fluorocytosine (5-FC) into the highly toxic 5-fluorouracil (5-FU). We investigated the antitumor effect of a new CD/5-FC system with CD cDNA transfected EPC for hepatocellular carcinoma (HCC) in mice. We used human hepatoma cell lines (HuH-7, HLF, HAK1-B, KYN-2, KIM-1) and a rat EPC cell line (TR-BME-2). Escherichia coli CD cDNA was transfected into TR-BME-2 (CD-TR-BME). The inhibitory effect of 5-FU on the proliferation of hepatoma cell lines and the inhibitory effect of 5-FU secreted by CD-TR-BME and 5-FC on the proliferation of cocultured hepatoma cells were evaluated by a tetrazolium-based assay. In mouse subcutaneous xenograft models of KYN-2 and HuH-7, CD-TR-BME was transplanted intravenously followed by 5-FC injection intraperitoneally. HuH-7 cells were the most sensitive to 5-FU and KYN-2 cells were the most resistant. CD-TR-BME secreted 5-FU and inhibited HuH-7 proliferation in a 5-FC dosedependent manner. CD-TR-BME were recruited into the tumor tissues and some were incorporated into tumor vessels. Tumor growth of HuH-7 was significantly suppressed during 5-FC administration. No bodyweight loss, ALT abnormality or bone marrow suppression was observed. These findings suggest that our new CD/5-FC system with CD cDNA transfected EPC could be an effective and safe treatment for suppression of 5-FU-sensitive HCC growth.

AB - The drug delivery system to tumors is a critical factor in upregulating the effect of anticancer drugs and reducing adverse events. Recent studies indicated selective migration of bone marrowderived endothelial progenitor cells (EPC) into tumor tissues. Cytosine deaminase (CD) transforms nontoxic 5-fluorocytosine (5-FC) into the highly toxic 5-fluorouracil (5-FU). We investigated the antitumor effect of a new CD/5-FC system with CD cDNA transfected EPC for hepatocellular carcinoma (HCC) in mice. We used human hepatoma cell lines (HuH-7, HLF, HAK1-B, KYN-2, KIM-1) and a rat EPC cell line (TR-BME-2). Escherichia coli CD cDNA was transfected into TR-BME-2 (CD-TR-BME). The inhibitory effect of 5-FU on the proliferation of hepatoma cell lines and the inhibitory effect of 5-FU secreted by CD-TR-BME and 5-FC on the proliferation of cocultured hepatoma cells were evaluated by a tetrazolium-based assay. In mouse subcutaneous xenograft models of KYN-2 and HuH-7, CD-TR-BME was transplanted intravenously followed by 5-FC injection intraperitoneally. HuH-7 cells were the most sensitive to 5-FU and KYN-2 cells were the most resistant. CD-TR-BME secreted 5-FU and inhibited HuH-7 proliferation in a 5-FC dosedependent manner. CD-TR-BME were recruited into the tumor tissues and some were incorporated into tumor vessels. Tumor growth of HuH-7 was significantly suppressed during 5-FC administration. No bodyweight loss, ALT abnormality or bone marrow suppression was observed. These findings suggest that our new CD/5-FC system with CD cDNA transfected EPC could be an effective and safe treatment for suppression of 5-FU-sensitive HCC growth.

UR - http://www.scopus.com/inward/record.url?scp=84859705390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859705390&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2011.02182.x

DO - 10.1111/j.1349-7006.2011.02182.x

M3 - Article

C2 - 22151662

AN - SCOPUS:84859705390

VL - 103

SP - 542

EP - 548

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 3

ER -